HEADER TRANSFERASE/INHIBITOR 30-AUG-17 5YA5 TITLE CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH NOVEL INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1038-1346; COMPND 5 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 6 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS C-MET INHIBITOR, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Q.LIU,Y.XU REVDAT 2 22-NOV-23 5YA5 1 REMARK REVDAT 1 04-JUL-18 5YA5 0 JRNL AUTH H.YUAN,Q.LIU,L.ZHANG,S.HU,T.CHEN,H.LI,Y.CHEN,Y.XU,T.LU JRNL TITL DISCOVERY, OPTIMIZATION AND BIOLOGICAL EVALUATION FOR NOVEL JRNL TITL 2 C-MET KINASE INHIBITORS JRNL REF EUR J MED CHEM V. 143 491 2018 JRNL REFN ISSN 1768-3254 JRNL PMID 29202410 JRNL DOI 10.1016/J.EJMECH.2017.11.073 REMARK 2 REMARK 2 RESOLUTION. 1.89 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.89 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.260 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 49227 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1464 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.9365 - 4.0708 0.98 4703 143 0.2040 0.2072 REMARK 3 2 4.0708 - 3.2315 1.00 4758 147 0.1948 0.1959 REMARK 3 3 3.2315 - 2.8231 1.00 4798 149 0.2218 0.2626 REMARK 3 4 2.8231 - 2.5651 1.00 4807 147 0.2233 0.2646 REMARK 3 5 2.5651 - 2.3812 1.00 4760 149 0.2238 0.2664 REMARK 3 6 2.3812 - 2.2408 1.00 4769 147 0.2191 0.2732 REMARK 3 7 2.2408 - 2.1286 1.00 4796 146 0.2118 0.2545 REMARK 3 8 2.1286 - 2.0360 1.00 4776 145 0.2147 0.2478 REMARK 3 9 2.0360 - 1.9576 1.00 4796 145 0.2260 0.2381 REMARK 3 10 1.9576 - 1.8900 1.00 4800 146 0.2319 0.2561 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.990 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2240 REMARK 3 ANGLE : 1.095 3041 REMARK 3 CHIRALITY : 0.081 340 REMARK 3 PLANARITY : 0.005 378 REMARK 3 DIHEDRAL : 16.034 810 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5YA5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1300004921. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49233 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.890 REMARK 200 RESOLUTION RANGE LOW (A) : 40.927 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.802 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.3300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.89 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.82 REMARK 200 R MERGE FOR SHELL (I) : 0.38800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.490 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4GG5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH7.5, 15% GLYCEROL, 12% REMARK 280 MPD, 5% ISOPROPANOL, 15% PEG5KMME, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.18000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.34500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 23.67000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.34500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.18000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 23.67000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1028 REMARK 465 GLY A 1029 REMARK 465 SER A 1030 REMARK 465 SER A 1031 REMARK 465 HIS A 1032 REMARK 465 HIS A 1033 REMARK 465 HIS A 1034 REMARK 465 HIS A 1035 REMARK 465 HIS A 1036 REMARK 465 HIS A 1037 REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 PRO A 1045 REMARK 465 LEU A 1046 REMARK 465 LEU A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ASP A 1099 REMARK 465 ASN A 1100 REMARK 465 ASP A 1101 REMARK 465 GLY A 1102 REMARK 465 ILE A 1115 REMARK 465 THR A 1116 REMARK 465 ASP A 1117 REMARK 465 ILE A 1118 REMARK 465 GLY A 1119 REMARK 465 GLU A 1120 REMARK 465 VAL A 1121 REMARK 465 LEU A 1147 REMARK 465 ARG A 1148 REMARK 465 SER A 1149 REMARK 465 GLU A 1150 REMARK 465 GLY A 1151 REMARK 465 GLY A 1346 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 ARG A1114 CG CD NE CZ NH1 NH2 REMARK 470 PHE A1124 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A1127 CD OE1 OE2 REMARK 470 SER A1152 OG REMARK 470 GLU A1172 CG CD OE1 OE2 REMARK 470 LYS A1240 CG CD CE NZ REMARK 470 LYS A1244 CG CD CE NZ REMARK 470 LYS A1323 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A1129 6.55 -58.19 REMARK 500 ARG A1203 -12.62 76.19 REMARK 500 ASP A1204 49.03 -146.23 REMARK 500 ALA A1221 -152.67 -131.70 REMARK 500 THR A1289 -70.90 -47.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 1288 THR A 1289 -149.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6TD A 1401 DBREF 5YA5 A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQADV 5YA5 MET A 1028 UNP P08581 INITIATING METHIONINE SEQADV 5YA5 GLY A 1029 UNP P08581 EXPRESSION TAG SEQADV 5YA5 SER A 1030 UNP P08581 EXPRESSION TAG SEQADV 5YA5 SER A 1031 UNP P08581 EXPRESSION TAG SEQADV 5YA5 HIS A 1032 UNP P08581 EXPRESSION TAG SEQADV 5YA5 HIS A 1033 UNP P08581 EXPRESSION TAG SEQADV 5YA5 HIS A 1034 UNP P08581 EXPRESSION TAG SEQADV 5YA5 HIS A 1035 UNP P08581 EXPRESSION TAG SEQADV 5YA5 HIS A 1036 UNP P08581 EXPRESSION TAG SEQADV 5YA5 HIS A 1037 UNP P08581 EXPRESSION TAG SEQRES 1 A 319 MET GLY SER SER HIS HIS HIS HIS HIS HIS GLY ASP SER SEQRES 2 A 319 ASP ILE SER SER PRO LEU LEU GLN ASN THR VAL HIS ILE SEQRES 3 A 319 ASP LEU SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL SEQRES 4 A 319 GLN HIS VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS SEQRES 5 A 319 PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL SEQRES 6 A 319 TYR HIS GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE SEQRES 7 A 319 HIS CYS ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE SEQRES 8 A 319 GLY GLU VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET SEQRES 9 A 319 LYS ASP PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY SEQRES 10 A 319 ILE CYS LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU SEQRES 11 A 319 PRO TYR MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG SEQRES 12 A 319 ASN GLU THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY SEQRES 13 A 319 PHE GLY LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SEQRES 14 A 319 SER LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 15 A 319 CYS MET LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP SEQRES 16 A 319 PHE GLY LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SEQRES 17 A 319 SER VAL HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS SEQRES 18 A 319 TRP MET ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR SEQRES 19 A 319 THR LYS SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP SEQRES 20 A 319 GLU LEU MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL SEQRES 21 A 319 ASN THR PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG SEQRES 22 A 319 ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR SEQRES 23 A 319 GLU VAL MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET SEQRES 24 A 319 ARG PRO SER PHE SER GLU LEU VAL SER ARG ILE SER ALA SEQRES 25 A 319 ILE PHE SER THR PHE ILE GLY HET 6TD A1401 26 HETNAM 6TD 2-[3-(4-METHOXYBENZYL)[1,2,4]TRIAZOLO[3,4-B][1,3, HETNAM 2 6TD 4]THIADIAZOL-6-YL]-1H-INDOLE HETSYN 6TD 6-(1H-INDOL-2-YL)-3-(4-METHOXYBENZYL)-[1,2, HETSYN 2 6TD 4]TRIAZOLO[3,4-B][1,3,4]THIADIAZOLE FORMUL 2 6TD C19 H15 N5 O S FORMUL 3 HOH *108(H2 O) HELIX 1 AA1 ASN A 1059 VAL A 1066 1 8 HELIX 2 AA2 GLY A 1072 SER A 1074 5 3 HELIX 3 AA3 GLN A 1123 GLY A 1128 1 6 HELIX 4 AA4 ILE A 1129 MET A 1131 5 3 HELIX 5 AA5 ASP A 1164 ASN A 1171 1 8 HELIX 6 AA6 THR A 1177 LYS A 1198 1 22 HELIX 7 AA7 ALA A 1206 ARG A 1208 5 3 HELIX 8 AA8 PHE A 1223 ARG A 1227 5 5 HELIX 9 AA9 ASP A 1231 TYR A 1235 5 5 HELIX 10 AB1 PRO A 1246 MET A 1250 5 5 HELIX 11 AB2 ALA A 1251 GLN A 1258 1 8 HELIX 12 AB3 THR A 1261 THR A 1278 1 18 HELIX 13 AB4 ASN A 1288 PHE A 1290 5 3 HELIX 14 AB5 ASP A 1291 GLN A 1298 1 8 HELIX 15 AB6 PRO A 1309 TRP A 1320 1 12 HELIX 16 AB7 LYS A 1323 ARG A 1327 5 5 HELIX 17 AB8 SER A 1329 THR A 1343 1 15 SHEET 1 AA1 5 LEU A1076 ARG A1086 0 SHEET 2 AA1 5 GLY A1090 LEU A1097 -1 O VAL A1092 N GLY A1085 SHEET 3 AA1 5 ILE A1105 LEU A1112 -1 O VAL A1109 N TYR A1093 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O VAL A1155 N LYS A1110 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N CYS A1146 O LEU A1154 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 2 SER A1236 VAL A1237 0 SHEET 2 AA3 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SITE 1 AC1 11 ALA A1108 TYR A1159 MET A1160 ASP A1164 SITE 2 AC1 11 ASN A1167 ARG A1208 MET A1211 ALA A1221 SITE 3 AC1 11 ASP A1222 ALA A1226 TYR A1230 CRYST1 42.360 47.340 158.690 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023607 0.000000 0.000000 0.00000 SCALE2 0.000000 0.021124 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006302 0.00000